Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1452-1457

  Ueno, Hiroki ^a   Koyama, Hidenori ^a   Tanaka, Shinji ^a   Fukumoto, Shinya ^a   Shinohara, Kayo ^a   Shoji, Tetsuo ^a   Emoto, Masanori ^a   Tahara, Hideki ^a   Kakiya, Ryusuke ^b   Tabata, Tsutomu ^b   Miyata, Toshio ^c   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Inoue Hospital   (Japan)

^c University of Tokyo   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGE DISTRIBUTION; ARTERIAL STIFFNESS; ARTICLE; AUTOFLUORESCENCE; BIOACCUMULATION; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; JAPANESE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULSE WAVE; SEX DIFFERENCE; SKIN TEST;

BRACHIAL ARTERY; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PULSATILE FLOW; SKIN; STATISTICS, NONPARAMETRIC; VASCULAR RESISTANCE;

EID: 51649086086     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.016     Document Type: Article

References (28)

1. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
2. Shoji T., Emoto M., Shinohara K., et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12 (2001) 2117-2124
3. Kitahara T., Ono K., Tsuchida A., et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 46 (2005) 688-696
4. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46 (1995) 223-234
5. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48 (1999) 1-9
6. Miyata T., Kurokawa K., and Van Ypersele De Strihou C. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11 (2000) 1744-1752
7. Makita Z., Radoff S., Rayfield E.J., et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325 (1991) 836-842
8. Miyata T., van Ypersele de Strihou C., Kurokawa K., and Baynes J.W. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 55 (1999) 389-399
9. Vishwanath V., Frank K.E., Elmets C.A., Dauchot P.J., and Monnier V.M. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes 35 (1986) 916-921
10. McCance D.R., Dyer D.G., Dunn J.A., et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91 (1993) 2470-2478
11. Beisswenger P.J., Makita Z., Curphey T.J., et al. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44 (1995) 824-829
12. Kass D.A., Shapiro E.P., Kawaguchi M., et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104 (2001) 1464-1470
13. Meerwaldt R., Graaff R., Oomen P.H., et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47 (2004) 1324-1330
14. Hartog J.W., de Vries A.P., Lutgers H.L., et al. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci 1043 (2005) 299-307
15. Lutgers H.L., Graaff R., Links T.P., et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 29 (2006) 2654-2659
16. Meerwaldt R., Links T.P., Graaff R., et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 48 (2005) 1637-1644
17. Meerwaldt R., Hartog J.W., Graaff R., et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16 (2005) 3687-3693
18. Meerwaldt R., Lutgers H.L., Links T.P., et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30 (2007) 107-112
19. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
20. Miyata T., van Ypersele de Strihou C., Ueda Y., et al. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 13 (2002) 2478-2487
21. Forbes J.M., Cooper M.E., Thallas V., et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51 (2002) 3274-3282
22. Sims T.J., Rasmussen L.M., Oxlund H., and Bailey A.J. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39 (1996) 946-951
23. Schram M.T., Schalkwijk C.G., Bootsma A.H., Fuller J.H., Chaturvedi N., and Stehouwer C.D. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 46 (2005) 232-237
24. Yoshida N., Okumura K., and Aso Y. High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 54 (2005) 345-350
25. Baynes J.W., and Thorpe S.R. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28 (2000) 1708-1716
26. Koyama H., Shoji T., Fukumoto S., et al. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 27 (2007) 147-153
27. Thomas M.C., Tsalamandris C., MacIsaac R., et al. Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int 66 (2004) 1167-1172
28. Monnier V.M., Sell D.R., and Genuth S. Glycation products as markers and predictors of the progression of diabetic complications. Ann N Y Acad Sci 1043 (2005) 567-581